Encision Inc (PK:ECIA)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 6797 Winchester Cir
BOULDER CO 80301-3513
Tel: 1-303-4442600
Website: https://www.encision.com
IR: See website
Key People
Patrick W. Pace
Executive Independent Chairman of the Board
Gregory J. Trudel
President, Chief Executive Officer, Director
David W. Newton
Co-Founder, Vice President -Technology, Director
Peter Geary
Vice President - Operations
Michael Biggs
Vice President- Product Development
Brad Greathouse
Vice President - Regulatory Affairs & Quality Assurance
Mala M Ray
Controller, Treasurer, corporate Secretary
Business Overview
Encision Inc. is a medical device company. The Company designs, develops, manufactures and markets surgical instruments that provide safety to patients undergoing minimally-invasive surgery. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause complications and even death. Its shielded and monitored instruments enable surgeons to perform electrosurgical procedures. It produces and markets a line of AEM Instruments, which are shielded and monitored to prevent stray electrosurgical burns from insulation failure and capacitive coupling. Its product line includes a range of endo-mechanical instruments (scissors, graspers and dissectors), fixed-tip electrodes and suction-irrigation electrodes. Its EndoShield integrates its AEM technology into a disposable smart cord and eliminates the need for a separate AEM monitor.
Financial Overview
For the fiscal year ended 31 March 2021, EncisionInc revenues decreased 2% to $7.5M. Net income totaled$585K vs. loss of $198K. Revenues reflect Product revenuedecrease of 9% to $7M. Net Income reflects Interest andother expense, net increase from $43K (expense) to $646K(income), Research and development decrease of 24% to $569K(expense), Sales and marketing decrease of 4% to $2M(expense).
Employees: 47 as of Mar 31, 2014
Reporting Currency: U.S. Dollars
Enterprise value: $10.88M as of Mar 31, 2021
Annual revenue (TTM): $7.54M as of Mar 31, 2021
EBITDA (TTM): $0.03M as of Mar 31, 2021
Net annual income (TTM): $0.58M as of Mar 31, 2021
Free cash flow (TTM): $0.18M as of Mar 31, 2021
Net Debt Last Fiscal Year: N/A
Shares outstanding: 11,582,641 as of Mar 31, 2021
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.